title: Additive Effects of Exenatide, Glucose-insulin-potassium, and Remote Ischemic Conditioning Against Reperfusion Ventricular Arrhythmias in Pigs.
authors.affiliation: Laboratorio de Cardiología Experimental, Servicio de Cardiología, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Juan J
authors.initials: JJ
authors.lastname: Alburquerque-Béjar
authors.affiliation: Laboratorio de Cardiología Experimental, Servicio de Cardiología, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Ignasi
authors.initials: I
authors.lastname: Barba
authors.affiliation: Laboratorio de Cardiología Experimental, Servicio de Cardiología, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Marisol
authors.initials: M
authors.lastname: Ruiz-Meana
authors.affiliation: Laboratorio de Cardiología Experimental, Servicio de Cardiología, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Laura
authors.initials: L
authors.lastname: Valls-Lacalle
authors.affiliation: Laboratorio de Cardiología Experimental, Servicio de Cardiología, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: antonio.rodriguez.sinovas@vhir.org.
authors.forename: Antonio
authors.initials: A
authors.lastname: Rodríguez-Sinovas
authors.affiliation: Laboratorio de Cardiología Experimental, Servicio de Cardiología, Institut de Recerca i Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: David
authors.initials: D
authors.lastname: García-Dorado
mesh_terms: D000818:Animals; D001145:Arrhythmias, Cardiac / Q000503:physiopathology / Q000517:prevention & control*; D018031:Connexin 43 / Q000187:drug effects / Q000378:metabolism; D004562:Electrocardiography; D000077270:Exenatide; D005947:Glucose / Q000494:pharmacology; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000494:pharmacology; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods*; D015428:Myocardial Reperfusion Injury / Q000503:physiopathology / Q000517:prevention & control*; D009206:Myocardium / Q000378:metabolism; D010455:Peptides / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology; D013549:Sweetening Agents / Q000627:therapeutic use*; D013552:Swine; D017180:Tachycardia, Ventricular / Q000503:physiopathology / Q000517:prevention & control; D014688:Venoms / Q000494:pharmacology*; D014693:Ventricular Fibrillation / Q000503:physiopathology / Q000517:prevention & control
chemical_list: D018031:Connexin 43; D007004:Hypoglycemic Agents; D007328:Insulin; D010455:Peptides; D013549:Sweetening Agents; D014688:Venoms; D000077270:Exenatide; D005947:Glucose; D011188:Potassium